InsidersTradesSigma
Follow the AdaptHealth Corp. stock price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, AdaptHealth Corp. has recorded 242 insider filings. Market capitalisation: €753.8m. The latest transaction was disclosed on 14 August 2026 (Acquisition). Among the most active insiders: Everest Hill Group Inc.. Every trade is openly available.
242
Insider Decl.
n/a
Thresholds
€23m
31 ops.
Buy Volume
€84m
50 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate AdaptHealth Corp. Strong Buy (bullish), based on 7 analysts. Average price target: US$9.14.
45Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,370 of 29,062 companies
43.7
score / 100
Value66
Quality22
FCF yld28%
Earn yld-9.2%
EV/EBITDA5.7x
ROE-15%
Gross mgn19%
Net mgn-2.2%
Debt/EBITDA4.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 August 2026
Declarations242 total
20,000 shares@ US$6.30Common StockSEC:0001104659-26-097053:0
Canonical exit: 4 Nov 2026 (T+90)
20,000 shares@ US$6.370.016% mcap15.5% of flowCommon StockSEC:0001104659-26-093575:0
Canonical exit: 4 Nov 2026 (T+90)
20,000 shares@ US$5.860.015% mcap14.3% of flowCommon StockSEC:0001104659-26-093575:1
Canonical exit: 5 Nov 2026 (T+90)
23,500 shares@ US$6.380.019% mcap100.0% of flowCommon StockSEC:0001104659-26-093576:0
Canonical exit: 4 Nov 2026 (T+90)
11,275 shares@ US$10.440.0080% mcap34.0% of flowCommon StockSEC:0001104659-26-080730:0
11,275 shares@ US$10.440.0085% mcap34.0% of flowCommonSEC144:0001959173-26-005003
18,999 sharesCommon StockSEC:0001104659-26-078238:0
6,070 sharesCommon StockSEC:0001104659-26-078238:1
18,999 sharesCommon StockSEC:0001104659-26-078240:0
18,999 sharesCommon StockSEC:0001104659-26-078257:0
18,999 sharesCommon StockSEC:0001104659-26-078262:0
18,999 sharesCommon StockSEC:0001104659-26-078264:0
18,999 sharesCommon StockSEC:0001104659-26-078281:0
18,999 sharesCommon StockSEC:0001104659-26-078285:0
18,999 sharesCommon StockSEC:0001104659-26-078268:0
11,275 shares@ US$10.060.0067% mcap100.0% of flowCommon StockSEC:0001104659-26-070230:0
20,134 shares0Common StockSEC:0001104659-26-068272:0
58,203 shares@ US$10.330.036% mcap49.7% of flowCommon StockSEC:0001104659-26-050577:0
727 shares@ US$9.94170.0004% mcap0.0% of flowCommon StockSEC:0001193125-26-132703:0
Canonical exit: 17 Jun 2026 (T+90)
820,528 shares@ US$9.72870.47% mcap50.0% of flowCommon StockSEC:0001193125-26-132663:0
Canonical exit: 8 Jun 2026 (T+90)
727 shares@ US$9.9417100.0% of flowCommon StockSEC:0001193125-26-120145:0
Canonical exit: 17 Jun 2026 (T+90)
89,451 shares@ US$4.3823.4% of flowCommon StockSEC:0001104659-26-028442:0
820,528 shares@ US$9.728799.9% of flowCommon StockSEC:0001193125-26-104760:0
Canonical exit: 8 Jun 2026 (T+90)
73,472 shares0Common StockSEC:0001104659-26-025412:0
8,000 shares@ US$8.9612.2% of flowCommon StockSEC:0001104659-26-023001:0
Canonical exit: 28 May 2026 (T+90)
25 of 242 declarations
关于 AdaptHealth Corp.
AdaptHealth Corp.（股票代码：AHCO）是一家在美国纳斯达克（而非纽约证券交易所）上市的美国医疗保健公司。公司总部位于美国宾夕法尼亚州康肖霍肯，已发展成为家庭医疗保健解决方案领域的全国性参与者，核心业务专注于家用医疗设备、医疗用品及相关服务。其商业模式以支持患者出院后或经医生转诊后的护理为中心，帮助将护理延伸至家庭，同时提高依从性、便利性和整体成本效益。（[adapthealth.com](https://adapthealth.com/2026/02/24/adapthealth-corp-announces-fourth-quarter-and-full-year-2025-results-and-provides-2026-financial-guidance/?utm_source=openai)） AdaptHealth 报告了四个与其产品类别相符的业务部门：睡眠健康、呼吸健康、糖尿病健康和居家健康。这种结构使公司能够接触到多个持久的医疗保健需求池，包括睡眠呼吸暂停和呼吸治疗、糖尿病护理和血糖监测，以及更广泛的居家健康和家庭护理解决方案。公司的产品组合包括连续血糖监测设备、胰岛素泵、呼吸设备和用品，以及其他家用医疗产品和服务。管理层将 AdaptHealth 定位为值得信赖的全国性医疗设备提供商网络，结合了临床产品、技术和患者支持。（[adapthealth.com](https://adapthealth.com/investorrelations/corporate-profile/?utm_source=openai)） 从竞争角度来看，AdaptHealth 在一个高度分散但竞争激烈的市场中运营，面临着 Owens & Minor、Lincare、Rotech、Cardinal Health 和 Quipt Home Medical 等全国性和区域性竞争对手。其战略优势在于规模、地理覆盖范围以及通过广泛的运营平台服务多个产品类别的能力。截至 2025 年底，公司表示每年为 48 个州的约 4.3 million 名患者提供服务，这突显了其在美国的广泛足迹和全国分销网络。（[sec.gov](https://www.sec.gov/Archives/edgar/data/1725255/000162828025007740/ahco-20241231.htm?utm_source=openai)） 近期发展主要集中在资产负债表修复和运营简化。2025 年，公司完成了某些非核心输液资产的出售，以帮助减少债务；2025 年 11 月，标普全球评级上调了 AdaptHealth 高级无抵押债务的发行级别评级。2026 年 2 月，AdaptHealth 公布了 2025 年全年业绩并发布了 2026 年指引，强调了运营现金流增长、多个类别的患者人数创纪录，以及收购夏威夷一家领先的 HME 提供商，这使公司的业务范围扩展到第 48 个州。因此，对于投资者而言，AHCO 是一个具有显著规模和结构性顺风的居家医疗保健公司，但它仍然对报销动态、患者数量和资本结构执行情况敏感。（[adapthealth.com](https://adapthealth.com/blogs/latest-news/adapthealth-corp-closes-transaction-to-dispose-of-certain-home-infusion-assets-and-reduces-debt?utm_source=openai)）
